Compound 150 displayed antiproliferative activity in MYC-driven cancer cells with GI50 values of 0.26, 0.49, 0.24, 1.2, 0.58, and 3.2 μM against CHP-134, Ramos, Raji, Daudi, and SW620 cell lines, respectively, although the MYC expressing human colon cancer cell line SW480 was resistant to treatment with compound 150. Here, MYC is linked to malignant colon neoplasm.